The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 01, 2017
RXi Pharmaceuticals and the CCIT at Herlev Hospital have entered into a collaborative research agreement to evaluate the potential of RXi's novel sd-...
read more
Wednesday, November 29, 2017
Rebiotix announced an expansion of the investigator sponsored Phase 1 study of RBX7455 for the prevention of recurrent Clostridium difficile infection...
read more
Tuesday, November 28, 2017
Viking Therapeutics announced positive results from a 12-week, Phase 2 clinical trial of VK5211 in patients who recently suffered a hip fracture.
read more
Tuesday, November 28, 2017
Egalet announced positive top-line results from a phase 3 study evaluating the efficacy and safety of Egalet-002, an abuse-deterrent, extended-release...
read more
Monday, November 27, 2017
Biohaven announced completion of enrollment in Study BHV3000-302, the company's second pivotal Phase 3 clinical trial examining the efficacy and ...
read more
Monday, November 27, 2017
Bayer announced that INHALE did not demonstrate superiority versus standard of care plus aerosolized placebo.
read more
Wednesday, November 22, 2017
FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with HIV-1.
read more
Wednesday, November 22, 2017
Nevakar announced the first subject has been dosed in a Phase 3 clinical trial of NVK-002.
read more
Wednesday, November 22, 2017
FDA issues guidance on development of generic abuse-deterrent opioids.
read more
Tuesday, November 21, 2017
The Leukemia & Lymphoma Society has committed an additional $46 million to fund the science at medical institutions around the world.
read more
Tuesday, November 21, 2017
The FDA has accepted and granted Priority Review of the NDA for lofexidine.
read more
Monday, November 20, 2017
Promentis announced that it has commenced a Phase 1 single ascending dose study for its lead compound, SXC-2023.
read more
Monday, November 20, 2017
ATCC announced the release of an in vitro model system for a key mechanism of invasion and metastasis in lung cancer.
read more
Thursday, November 16, 2017
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and ...
read more
Thursday, November 16, 2017
Celgene and bluebird bio announced that bb2121 has been granted Breakthrough Therapy Designation by the FDA.
read more